Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

AC Immune and Belgian KUL design new products for tau-related disorders

May 10, 2012

Purdue Pharma develops novel sodium channel antagonists

May 10, 2012

Cadila Healthcare discovers novel GPR119 receptor agonists

May 10, 2012

Novel cyclopropylamines presented by Oryzon Genomics

May 10, 2012

GSK patents new transient receptor potential TRPV1 channel antagonists

May 10, 2012

NoNO divulges novel peptides with therapeutic potential

May 9, 2012

New PI3K inhibitors discovered at Millennium Pharmaceuticals

May 9, 2012

Boehringer Ingelheim develops new candidate hepatitis therapies

May 9, 2012

Investigation at Roche yields novel TWEAK-specific antibodies

May 8, 2012

New candidate drugs for tuberculosis designed at GSK

May 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...